MedTrace Logo

Non-invasive Brain Stimulation as a Treatment for Dysarthria Post-stroke

NCT05497362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-09-02

No results posted yet for this study

Summary

The proposed study aimed to determine if tDCS can help post-stroke patients with dysarthria.

Conditions

Interventions

DEVICE

Real tDCS

2mA of tDCS was delivered to the orofacial area of the primary motor cortex (SM1) for 15 minutes. Speech therapy was delivered simultaneously.

DEVICE

Sham tDCS

2mA of tDCS was delivered to the orofacial area of the primary motor cortex (SM1) for 30 sec. Speech therapy was delivered simultaneously.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Manwa L Ng, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05497362 on ClinicalTrials.gov